AT&T Honored for Unwavering Commitment to Connecting Georgians to Greater Possibility — Neutral
T Business Wire — November 20, 2025ATLANTA--(BUSINESS WIRE)-- #atlantabusiness--goBeyondProfit, a first-of-its-kind business leader initiative that inspires business generosity, today announced AT&T Georgia as the recipient of the 2025 goBeyondProfit Champion Award. AT&T was nominated and selected by fellow Georgia business leaders for its commitment to connecting Georgians to greater possibility, demonstrating that purpose and profit are intrinsically linked. The award recognizes AT&T's work across Georgia, showcasing how the company'.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO — Neutral
ALVO PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
California Resources Corporation Supports Food Security Efforts Across California with $200,000 Donation — Neutral
CRC GlobeNewsWire — November 20, 2025LONG BEACH, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) today announced it is donating $200,000 to support community food security efforts across the state.
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm — Neutral
ATYR GlobeNewsWire — November 20, 2025LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against aTyr Pharma, Inc. (“aTyr” or “the Company”) (NASDAQ: ATYR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before December 8, 2025.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkami Technology, Inc. - ALKT — Neutral
ALKT PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alkami Technology, Inc. ("Alkami" or the "Company") (NASDAQ: ALKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savers Value Village, Inc. - SVV — Neutral
SVV PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Savers Value Village, Inc. ("Savers" or the "Company") (NYSE: SVV). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beyond Meat, Inc. - BYND — Neutral
BYND PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Beyond Meat, Inc. ("Beyond Meat" or the "Company") (NASDAQ: BYND). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Live Oak Bancshares, Inc. - LOB — Neutral
LOB PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Live Oak Bancshares, Inc. ("Live Oak" or the "Company") (NYSE: LOB). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Regencell Bioscience Holdings Limited - RGC — Neutral
RGC PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Western Alliance Bancorporation - WAL — Neutral
WAL PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Western Alliance Bancorporation ("Western Alliance" or the "Company") (NYSE: WAL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zions Bancorporation, N.A. - ZION — Neutral
ZION PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zions Bancorporation, N.A. ("Zions" or the "Company") (NASDAQ: ZION).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of uniQure N.V. - QURE — Neutral
QURE PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens Corning - OC — Neutral
OC PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Owens Corning ("Owens Corning" or the "Company") (NYSE: OC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zimmer Biomet Holdings, Inc. - ZBH — Neutral
ZBH PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet" or the "Company") (NYSE: ZBH). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Varonis Systems, Inc. - VRNS — Neutral
VRNS PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. - PETS — Neutral
PETS PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ: PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO — Neutral
SLNO PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ: SLNO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of VirTra, Inc. - VTSI — Neutral
VTSI PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of VirTra, Inc. ("VirTra" or the "Company") (NASDAQ: VTSI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bitdeer Technologies Group - BTDR — Neutral
BTDR PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bitdeer Technologies Group ("Bitdeer" or the "Company") (NASDAQ: BTDR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of agilon health, Inc. - AGL — Neutral
AGL PRNewsWire — November 20, 2025NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE: AGL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.